Gene	Study of Origin	Sample ID	Cancer Type	Cancer Type Detailed	Protein Change	Annotation	Custom Driver	Custom Driver Tiers	Functional Impact	Mutation Type	Variant Type	Copy #	MS	VS	Center	Chromosome	Start Pos	End Pos	Ref	Var	HGVSg	HGVSc	Allele Freq (T)	Allele Freq (N)	Variant Reads	Ref Reads	Variant Reads (Normal)	Ref Reads (Normal)	# Mut in Sample	Exon	gnomAD	ClinVar	dbSNP	SIGNAL	Diagnosis Age	Neoplasm Disease Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Publication Version Type	Aneuploidy Score	Buffa Hypoxia Score	TCGA PanCanAtlas Cancer Type Acronym	Last Communication Contact from Initial Pathologic Diagnosis Date	Birth from Initial Pathologic Diagnosis Date	Last Alive Less Initial Pathologic Diagnosis Date Calculated Day Value	Disease Free (Months)	Disease Free Status	Months of disease-specific survival	Disease-specific Survival status	Ethnicity Category	Form completion date	Fraction Genome Altered	Genetic Ancestry Label	Neoplasm Histologic Grade	Neoadjuvant Therapy Type Administered Prior To Resection Text	ICD-10 Classification	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Histology Code	International Classification of Diseases for Oncology, Third Edition ICD-O-3 Site Code	In PanCan Pathway Analysis	Informed consent verified	MSI MANTIS Score	MSIsensor Score	New Neoplasm Event Post Initial Therapy Indicator	Oncotree Code	Overall Survival (Months)	Overall Survival Status	Other Patient ID	American Joint Committee on Cancer Metastasis Stage Code	Neoplasm Disease Lymph Node Stage American Joint Committee on Cancer Code	American Joint Committee on Cancer Tumor Stage Code	Person Neoplasm Cancer Status	Progress Free Survival (Months)	Progression Free Status	Primary Lymph Node Presentation Assessment	Prior Diagnosis	Race Category	Radiation Therapy	Ragnum Hypoxia Score	Number of Samples Per Patient	Sample Type	Sex	Somatic Status	Subtype	Tumor Break Load	Tissue Prospective Collection Indicator	Tissue Retrospective Collection Indicator	Tissue Source Site	Tissue Source Site Code	TMB (nonsynonymous)	Tumor Disease Anatomic Site	Tumor Type	Patient Weight	Winter Hypoxia Score
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-09-2050-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	S1882*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	13	32914137	32914137	C	A	13:g.32914137C>A	ENST00000544455.1:c.5645C>A	0.96		52	2		66	107	11/28	0.0000160375	Pathogenic	rs80358785		65			10		OV	2163	-23987	0	71.11154946	0:DiseaseFree	71.11154946	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	11/3/09	0.9166	EUR	G2	No	C56.9	8441/3	C56.9	No	Yes	0.2972	1.36		SOC	71.11154946	0:LIVING	3c037acf-f453-4513-a6dd-129163ddde2a				Tumor Free	71.11154946	0:CENSORED			White	No		1	Primary	Female	Matched		137			UCSF	9	3.533333333	Ovary	Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-0885-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	K1406Nfs*3	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	13	32912708	32912711	AAAG	-	13:g.32912708_32912711del	ENST00000544455.1:c.4218_4221del	0.60		29	19		126	181	11/28		Pathogenic						23		OV				111.3850807	0:DiseaseFree	111.3850807	0:ALIVE OR DEAD TUMOR FREE			0.6189	EUR						No		0.2821	0.72		SOC	111.3850807	0:LIVING						111.3850807	0:CENSORED						1	Primary		Matched		308			Memorial Sloan Kettering	13	6.066666667		Ovarian Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-04-1331-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	C711*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	13	32910625	32910625	C	A	13:g.32910625C>A	ENST00000544455.1:c.2133C>A	0.78		38	11		98	135	11/28		Pathogenic	rs535547513		78			7		OV	1224	-28848	0	15.09024559	1:Recurred/Progressed	43.92280633	1:DEAD WITH TUMOR	Not Hispanic Or Latino	3/26/09	0.4372	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2781	0.75		SOC	43.92280633	1:DECEASED	6d10d4ee-6331-4bba-93bc-a7b64cc0b22a				With Tumor	15.09024559	1:PROGRESSION			White	No		1	Primary	Female	Matched		109			Gynecologic Oncology Group	4	4.5	Ovary	Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-0890-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	S1230Lfs*9	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	13	32912178	32912178	T	-	13:g.32912178del	ENST00000544455.1:c.3688del	0.38		54	88		206	75	11/28		Pathogenic						12	31	OV				145.4449814	0:DiseaseFree	145.4449814	0:ALIVE OR DEAD TUMOR FREE			0.5853	EUR						Yes		0.2791	0.5		SOC	145.4449814	0:LIVING						145.4449814	0:CENSORED					10	1	Primary		Matched	OV	170			Memorial Sloan Kettering	13	2.5		Ovarian Serous Cystadenocarcinoma		34
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-1481-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	S2697Kfs*31	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	13	32937426	32937441	TGAGCGCAAATATATC	-	13:g.32937426_32937441del	ENST00000544455.1:c.8090_8105del	0.46		156	181		426	227	18/28		Pathogenic			76			7	23	OV	2648	-27898	0	87.0565802	0:DiseaseFree	87.0565802	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	3/31/09	0.4085	EUR	G2	No	C56.9	8441/3	C56.9	Yes	Yes	0.273	0.23		SOC	87.0565802	1:DECEASED	c5355491-e1e8-46a4-a05e-bafcaf2e7459				Tumor Free	87.0565802	0:CENSORED			White	No	8	1	Primary	Female	Matched	OV	227			Memorial Sloan Kettering	13	7.7	Ovary	Serous Cystadenocarcinoma		30
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-0889-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	T2517Hfs*22	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Ins	INS	Diploid	.	.	.	13	32930676	32930677	-	A	13:g.32930676_32930677insA	ENST00000544455.1:c.7547_7548insA	0.09		9	93		360	1070	15/28								4		OV						95.1441628	0:ALIVE OR DEAD TUMOR FREE			0.2824	EUR						No		0.4005	0		SOC	95.1441628	1:DECEASED						95.1441628	0:CENSORED						1	Primary		Matched		173			Memorial Sloan Kettering	13	35.7		Ovarian Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-13-0889-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	V3283Afs*2	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Ins	INS	Diploid	.	.	.	13	32972497	32972498	-	C	13:g.32972497_32972498insC	ENST00000544455.1:c.9847_9848insC	0.09		10	99		418	1070	27/28								4		OV						95.1441628	0:ALIVE OR DEAD TUMOR FREE			0.2824	EUR						No		0.4005	0		SOC	95.1441628	1:DECEASED						95.1441628	0:CENSORED						1	Primary		Matched		173			Memorial Sloan Kettering	13	35.7		Ovarian Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-29-1693-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	L3172Afs*44	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Frame_Shift_Del	DEL	ShallowDel	.	.	.	13	32971045	32971048	TACT	-	13:g.32971045_32971048del	ENST00000544455.1:c.9513_9516del	0.86		172	29		346	101	26/28		Pathogenic			72			13	15	OV	3096	-26300	0	22.81618832	1:Recurred/Progressed	101.7851859	0:ALIVE OR DEAD TUMOR FREE		6/2/09	0.6489	EUR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.269	1.5		SOC	101.7851859	0:LIVING	6fb71a0c-bc50-48c8-acfa-db94be1e151a				With Tumor	22.81618832	1:PROGRESSION			White	No	0	1	Primary	Female	Matched	OV	205			Duke	29	3.4	Ovary	Serous Cystadenocarcinoma		28
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-29-1762-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	E2906*	OncoKB: Likely Oncogenic, level_1, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: NA;SIFT: NA;Polyphen-2: NA;AlphaMissense: NA	Nonsense_Mutation	SNP	ShallowDel	.	.	.	13	32950890	32950890	G	T	13:g.32950890G>T	ENST00000544455.1:c.8716G>T	0.75		12	4		35	69	21/28					59			14	25	OV	2606	-21879	0			86.59631127	1:DEAD WITH TUMOR		6/2/09	0.9340	EUR	G2	No	C56.9	8441/3	C56.9	Yes	Yes	0.2844	1.1		SOC	86.59631127	1:DECEASED	5495b18a-10ec-427b-83b8-03ef4b587b13				With Tumor	45.20498406	1:PROGRESSION			White	No	16	1	Primary	Female	Matched	OV	88			Duke	29	2.3	Ovary	Serous Cystadenocarcinoma		22
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-25-1320-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	V3079I	OncoKB: Likely Neutral, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: neutral, score: 2.1735234578889275;SIFT: impact: tolerated, score: 0.38;Polyphen-2: impact: benign, score: 0.056;AlphaMissense: pathogenicity: benign, score: 0.074	Missense_Mutation	SNP	Gain	.	.	.	13	32954261	32954261	G	A	13:g.32954261G>A	ENST00000544455.1:c.9235G>A	0.21		21	79		73	114	24/28	0.00032625039008198813	Benign	rs55933907	0.00035	65			25	19	OV	1124	-24018	0			37.97218661	1:DEAD WITH TUMOR	Not Hispanic Or Latino	3/27/09	0.6540	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.3099	0.6		SOC	37.97218661	1:DECEASED	46395c3d-5e51-477f-946e-e58b87cc7baa				With Tumor	13.93957327	1:PROGRESSION			White	No	14	1	Primary	Female	Matched		368			Mayo Clinic - Rochester	25	3.833333333	Ovary	Serous Cystadenocarcinoma		12
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-24-1103-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	K1638E	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: low, score: 3.3148758542781724;SIFT: impact: tolerated, score: 0.38;Polyphen-2: impact: benign, score: 0.075;AlphaMissense: pathogenicity: benign, score: 0.0797	Missense_Mutation	SNP	ShallowDel	.	.	.	13	32913404	32913404	A	G	13:g.32913404A>G	ENST00000544455.1:c.4912A>G	0.93		77	6		176	66	11/28		Conflicting_classifications_of_pathogenicity(Uncertain_significance(2)|Likely_benign(1))	rs886040553		50			4	15	OV	1646	-18583	0	22.29016668	1:Recurred/Progressed	54.11447546	1:DEAD WITH TUMOR		3/9/09	0.6776	AFR	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.2814	2.33		SOC	54.11447546	1:DECEASED	f34aa3b6-e966-49c6-bc55-130545772c53				With Tumor	22.29016668	1:PROGRESSION			Black or African American	No	12	1	Primary	Female	Matched	OV	161			Washington University	24	2.2	Ovary	Serous Cystadenocarcinoma		26
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-23-1030-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	T1354M	OncoKB: Inconclusive, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: neutral, score: 1.985145956776061;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: benign, score: 0.01;AlphaMissense: pathogenicity: benign, score: 0.0874	Missense_Mutation	SNP	Diploid	.	.	.	13	32912553	32912553	C	T	13:g.32912553C>T	ENST00000544455.1:c.4061C>T	0.20		14	56		80	48	11/28	0.00013458362735612283	Benign	rs80358656	0.0011	64			17		OV	886	-23416	0	17.88473551	1:Recurred/Progressed	29.12844791	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	2/24/09	0.4773	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2917	0.65		SOC	29.12844791	0:LIVING	cbcf6922-a3c0-43a1-826e-642918b0a635				Tumor Free	17.88473551	1:PROGRESSION			White	No		1	Primary	Female	Matched		309			Cedars Sinai	23	1.6	Ovary	Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-04-1356-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	N1906I	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: low, score: 4.436313682959418;SIFT: impact: deleterious, score: 0;Polyphen-2: impact: probably_damaging, score: 0.968;AlphaMissense: pathogenicity: benign, score: 0.1025	Missense_Mutation	SNP	Diploid	.	.	.	13	32914209	32914209	A	T	13:g.32914209A>T	ENST00000544455.1:c.5717A>T	0.06	0.0046	12	180	1	218	88	11/28					62			16		OV		-22855	0			49.28165171	1:DEAD WITH TUMOR	Hispanic Or Latino	3/26/09	0.7459		G3	No	C56.9	8441/3	C56.9	No	Yes	0.2839	0.79		SOC	49.28165171	1:DECEASED	8652ddee-98f4-4584-b450-e6f2f5c9d7ec				With Tumor	5.128710918	1:PROGRESSION			White	No		1	Primary	Female	Matched		257			Gynecologic Oncology Group	4	2.933333333	Ovary	Serous Cystadenocarcinoma		
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-09-2044-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	Q1934K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: low, score: 3.207626409760519;SIFT: impact: tolerated, score: 0.17;Polyphen-2: impact: benign, score: 0.013;AlphaMissense: pathogenicity: benign, score: 0.0651	Missense_Mutation	SNP	Diploid	.	.	.	13	32914292	32914292	C	A	13:g.32914292C>A	ENST00000544455.1:c.5800C>A	0.09		6	61		79	1893	11/28					77			9	21	OV	186	-28231	0	6.115001479	0:DiseaseFree	6.115001479	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	11/2/09	0.6316	EAS	G3	No	C56.9	8441/3	C56.9	Yes	Yes	0.3147	0.58		SOC	6.115001479	0:LIVING	7d03ddb6-f3fe-4b50-8bba-514aa65e7d0e				Tumor Free	6.115001479	0:CENSORED			Asian	No	8	1	Primary	Female	Matched	OV	321			UCSF	9	63.43333333	Ovary	Serous Cystadenocarcinoma		10
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-61-1737-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	T1225K	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: neutral, score: 1.7697779075174969;SIFT: impact: tolerated, score: 0.21;Polyphen-2: impact: benign, score: 0.003;AlphaMissense: pathogenicity: benign, score: 0.1003	Missense_Mutation	SNP	ShallowDel	.	.	.	13	32912166	32912166	C	A	13:g.32912166C>A	ENST00000544455.1:c.3674C>A	0.09		8	80		212	123	11/28		Conflicting_classifications_of_pathogenicity(Uncertain_significance(1)|Likely_benign(1))	rs1490822985		42			10	31	OV	1364	-15515	0			44.84334418	0:ALIVE OR DEAD TUMOR FREE	Not Hispanic Or Latino	6/2/09	0.4436	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2533	0.85		SOC	44.84334418	0:LIVING	0aa020cb-69d2-4235-a609-c279a133d8bb				Tumor Free	44.84334418	0:CENSORED			White	No	12	1	Primary	Female	Matched		91			University of Pittsburgh	61	4.166666667	Ovary	Serous Cystadenocarcinoma		46
BRCA2	Ovarian Serous Cystadenocarcinoma (TCGA, PanCancer Atlas)	TCGA-61-1903-01	Ovarian Epithelial Tumor	Serous Ovarian Cancer	N1910S	OncoKB: Unknown, level NA, resistance NA;CIViC: NA;CancerHotspot: no;3DHotspot: no			MutationAssessor: impact: neutral, score: -0.23017668670678698;SIFT: impact: tolerated, score: 0.8;Polyphen-2: impact: benign, score: 0;AlphaMissense: pathogenicity: benign, score: 0.0567	Missense_Mutation	SNP	ShallowDel	.	.	.	13	32914221	32914221	A	G	13:g.32914221A>G	ENST00000544455.1:c.5729A>G	0.78		62	17		180	53	11/28		Conflicting_classifications_of_pathogenicity(Uncertain_significance(4)|Likely_benign(2))	rs276174863		55			7		OV	396	-20381	0	13.01903541	0:DiseaseFree	13.01903541	0:ALIVE OR DEAD TUMOR FREE		10/1/09	0.4249	EUR	G3	No	C56.9	8441/3	C56.9	No	Yes	0.2826	1.26		SOC	13.01903541	0:LIVING	b3df9c0a-420c-4cc2-a3e0-56df1ed7e997				Tumor Free	13.01903541	0:CENSORED			White	No		1	Primary	Female	Matched		184			University of Pittsburgh	61	1.8	Ovary	Serous Cystadenocarcinoma		
